G W Wilkinson|P R Lowenstein - JoVE Visualize

Showing results (121-130 of 128) with videos related to

Pageof 13

Sort By:

You have reached the last page of results.This site can display upto 128 results.

Journal of Immunology (Baltimore, Md. : 1950)|May 9, 2000

Tolerance to cardiac allografts via local and systemic mechanisms after adenovirus-mediated CTLA4Ig expressionC Guillot, P Mathieu, H Coathalem, et al.

Science (New York, N.Y.)|February 11, 2000

Surface expression of HLA-E, an inhibitor of natural killer cells, enhanced by human cytomegalovirus gpUL40P Tomasec, V M Braud, C Rickards, et al.

Human Gene Therapy|May 24, 2006

Quantification of high-capacity helper-dependent adenoviral vector genomes in vitro and in vivo, using quantitative TaqMan real-time polymerase chain reactionM Puntel, J F Curtin, J M Zirger, et al.

Gene Therapy|May 9, 2000

Central nervous system toxicity of two adenoviral vectors encoding variants of the herpes simplex virus type 1 thymidine kinase: reduced cytotoxicity of a truncated HSV1-TKC Cowsill, T D Southgate, G Morrissey, et al.

Molecular Therapy : the Journal of the American Society of Gene Therapy|June 11, 2005

Regulatable gene expression systems for gene therapy applications: progress and future challengesS Goverdhana, M Puntel, W Xiong, et al.

Lancet (London, England)|June 1, 1996

A recombinant vaccinia virus encoding human papillomavirus types 16 and 18, E6 and E7 proteins as immunotherapy for cervical cancerL K Borysiewicz, A Fiander, M Nimako, et al.

Journal of Virology|December 17, 2008

Herpes simplex virus type 1 thymidine kinase sequence fused to the lacz gene increases levels of {beta}-galactosidase activity per genome of high-capacity but not first-generation adenoviral vectors in vitro and in vivoM Puntel, R J Barrett, S Mondkar, et al.

Clinical Pharmacology and Therapeutics|February 19, 2010

Study of the efficacy, biodistribution, and safety profile of therapeutic gutless adenovirus vectors as a prelude to a phase I clinical trial for glioblastomaA K M G Muhammad, M Puntel, M Candolfi, et al.

Pageof 13

Showing results (121-130 of 128) with videos related to

Sort By:

Pageof 13

You have reached the last page of results.This site can display upto 128 results.

Journal of Immunology (Baltimore, Md. : 1950)|May 9, 2000

Tolerance to cardiac allografts via local and systemic mechanisms after adenovirus-mediated CTLA4Ig expressionC Guillot, P Mathieu, H Coathalem, et al.

Science (New York, N.Y.)|February 11, 2000

Surface expression of HLA-E, an inhibitor of natural killer cells, enhanced by human cytomegalovirus gpUL40P Tomasec, V M Braud, C Rickards, et al.

Human Gene Therapy|May 24, 2006

Quantification of high-capacity helper-dependent adenoviral vector genomes in vitro and in vivo, using quantitative TaqMan real-time polymerase chain reactionM Puntel, J F Curtin, J M Zirger, et al.

Gene Therapy|May 9, 2000

Central nervous system toxicity of two adenoviral vectors encoding variants of the herpes simplex virus type 1 thymidine kinase: reduced cytotoxicity of a truncated HSV1-TKC Cowsill, T D Southgate, G Morrissey, et al.

Molecular Therapy : the Journal of the American Society of Gene Therapy|June 11, 2005

Regulatable gene expression systems for gene therapy applications: progress and future challengesS Goverdhana, M Puntel, W Xiong, et al.

Lancet (London, England)|June 1, 1996

A recombinant vaccinia virus encoding human papillomavirus types 16 and 18, E6 and E7 proteins as immunotherapy for cervical cancerL K Borysiewicz, A Fiander, M Nimako, et al.

Journal of Virology|December 17, 2008

Herpes simplex virus type 1 thymidine kinase sequence fused to the lacz gene increases levels of {beta}-galactosidase activity per genome of high-capacity but not first-generation adenoviral vectors in vitro and in vivoM Puntel, R J Barrett, S Mondkar, et al.

Clinical Pharmacology and Therapeutics|February 19, 2010

Study of the efficacy, biodistribution, and safety profile of therapeutic gutless adenovirus vectors as a prelude to a phase I clinical trial for glioblastomaA K M G Muhammad, M Puntel, M Candolfi, et al.

Pageof 13